Physician profile
Pragati Hooda
NPI 1962735670
$587.04
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.09 · 2020: $27.05 · 2021: $65.84 · 2022: $303 · 2023: $176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $176.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $175.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $95.40 | 2022-2023 | Trulicity, Mounjaro |
| Astrazeneca Pharmaceuticals LP | $76.22 | 2022-2023 | Farxiga |
| Abbvie INC. | $49.37 | 2022-2023 | |
| Idorsia Pharmaceuticals US INC | $40.80 | 2022-2023 | Quviviq |
| Lucid Diagnostics INC. | $35.45 | 2022 | |
| Pfizer INC. | $32.98 | 2023 | |
| Glaxosmithkline, LLC. | $32.01 | 2020-2023 | Trelegy Ellipta |
| Novo Nordisk INC | $29.93 | 2022 | |
| Sanofi Pasteur INC. | $26.50 | 2022 | |
| Alkermes, INC. | $21.48 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $19.84 | 2022 | |
| Janssen Pharmaceuticals, INC | $17.13 | 2021 | |
| Smith+Nephew, INC. | $16.94 | 2022 | |
| Amgen INC. | $15.71 | 2021 | |
| Boston Scientific Corporation | $15.09 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $13.46 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $13.02 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $12.32 | 2022 | |
| Ferring Pharmaceuticals INC. | $11.87 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $11.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pragati Hooda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.